Randomized Phaseii Trial To Evaluate Alisertib Alone Or Combined With Fulvestrant For Advanced, Endocrine-Resistant Breast Cancer (Tbcrc 041)

CANCER RESEARCH(2021)

引用 1|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要